Musculoskeletal Deficits and Cognitive Impairment: Epidemiological Evidence and Biological Mechanisms

Curr Osteoporos Rep. 2022 Oct;20(5):260-272. doi: 10.1007/s11914-022-00736-9. Epub 2022 Jun 29.

Abstract

Purpose of review: Cognitive impairment is associated with obesity, sarcopenia, and osteoporosis. However, no critical appraisal of the literature on the relationship between musculoskeletal deficits and cognitive impairment, focusing on the epidemiological evidence and biological mechanisms, has been published to date. Herein, we critically evaluate the literature published over the past 3 years, emphasizing interesting and important new findings, and provide an outline of future directions that will improve our understanding of the connections between the brain and the musculoskeletal system.

Recent findings: Recent literature suggests that musculoskeletal deficits and cognitive impairment share pathophysiological pathways and risk factors. Cytokines and hormones affect both the brain and the musculoskeletal system; yet, lack of unified definitions and standards makes it difficult to compare studies. Interventions designed to improve musculoskeletal health are plausible means of preventing or slowing cognitive impairment. We highlight several musculoskeletal health interventions that show potential in this regard.

Keywords: Bone; Cognition; Muscle; Musculoskeletal system; Nervous system.

Publication types

  • Review
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cognitive Dysfunction* / epidemiology
  • Cognitive Dysfunction* / metabolism
  • Cytokines / metabolism
  • Hormones / metabolism
  • Humans
  • Musculoskeletal System* / metabolism
  • Sarcopenia* / metabolism

Substances

  • Cytokines
  • Hormones